Efficacy and Safety of Upadacitinib Treatment for Moderate to Severe Atopic Dermatitis in Real-World Practice in Japan
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan
J Dermatol 2022 Aug 19;[EPub Ahead of Print], T Hagino, H Saeki, N KandaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.